Abstract
We sought to review the appropriate patient selection criteria, available clinical literature, technical modifications, and future directions associated with the use of robotic technology to perform salvage robotic-assisted radical prostatectomy (SRARP). Recent studies have investigated the emerging role of SRARP following primary focal therapies, imaging technologies for preoperative staging and risk assessment, and novel bioengineering and technical modifications to improve postoperative functional outcomes. SRARP represents a potentially curative but underutilized treatment for men who develop localized recurrence of prostate cancer (PCa) following primary radiotherapy treatment or primary focal therapy. While SRARP may be associated with potentially significant complications including rectal injury, erectile dysfunction, and stress urinary incontinence, several centers have published their experience with the procedure and several technical modifications to the standard RALP have been utilized to reduce the risk of these potential treatment side effects. Further standardization of pathology reporting, novel technological and imaging advances, and multi-institutional collaboration will be necessary to improve future SRARP outcomes.
Similar content being viewed by others
Data Availability
Not applicable.
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990–2013. JAMA. 2015;314(1):80–2.
Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–24.
Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28(7):1117–23.
Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007;67(2):327–33.
Zagars GK, Pollack A, von Eschenbach AC. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys. 1995;33(1):23–35.
Abern MR, Tsivian M, Polascik TJ. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep. 2012;13(2):160–9.
Perera M, Krishnananthan N, Lindner U, Lawrentschuk N. An update on focal therapy for prostate cancer. Nat Rev Urol. 2016;13(11):641–53.
Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, et al. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys. 1991;21(3):537–47.
Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol. 2002;168(2):530–5.
Lee WR, Hanks GE, Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol. 1997;15(1):230–8.
Deger S, Boehmer D, Roigas J, Schink T, Wernecke KD, Wiegel T, et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol. 2005;47(4):441–8.
Marcus DM, et al. Salvage therapy for locally recurrent prostate cancer after radiation. Can J Urol. 2012;19(6):6534–41.
Dobbs RW, Kocjancic E, Crivellaro S. Male stress urinary incontinence following surgical intervention: procedures, technical modifications, and patient considerations. In: Del Popolo G, Pistolesi D, Marzi VL, editors. Male stress urinary incontinence. Cham: Springer International Publishing; 2015. p. 45–72.
Acar O, Esen T. Robotic radical prostatectomy in patients with previous prostate surgery and radiotherapy. Prostate Cancer. 2014;2014:367675.
Meeks JJ, Walker M, Bernstein M, Kent M, Eastham JA. Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy. BJU Int. 2013;112(3):308–12.
Roach M 3rd, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65(4):965–74.
Greene KL, et al. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013;189(1 Suppl):S2–S11.
Muller BG, van den Bos W, Brausi M, Fütterer JJ, Ghai S, Pinto PA, et al. Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project. World J Urol. 2015;33(10):1503–9.
Rouviere O, Vitry T, Lyonnet D. Imaging of prostate cancer local recurrences: why and how? Eur Radiol. 2010;20(5):1254–66.
van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, et al. (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment. BJU Int. 2016;117(5):732–9.
Obek C, et al. The accuracy of (68)Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer. Eur J Nucl Med Mol Imaging. 2017;44(11):1806–12.
Gupta M, Choudhury PS, Hazarika D, Rawal S. A comparative study of (68)gallium-prostate specific membrane antigen positron emission tomography-computed tomography and magnetic resonance imaging for lymph node staging in high risk prostate cancer patients: an initial experience. World J Nucl Med. 2017;16(3):186–91.
Chen BT, Wood DP Jr. Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer. Urology. 2003;62(Suppl 1):69–78.
Kaouk JH, Hafron J, Goel R, Haber GP, Jones JS. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results. BJU Int. 2008;102(1):93–6.
Boris RS, Bhandari A, Krane LS, Eun D, Kaul S, Peabody JO. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. BJU Int. 2009;103(7):952–6.
Eandi JA, Link BA, Nelson RA, Josephson DY, Lau C, Kawachi MH, et al. Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer. J Urol. 2010;183(1):133–7.
Strope SA, Coelho M, Wood DP, Hollenbeck BK. Robot-assisted salvage prostatectomy: evaluation of initial patient-reported outcomes. J Endourol. 2010;24(3):425–7.
Chauhan S, Patel MB, Coelho R, Liss M, Rocco B, Sivaraman AK, et al. Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes. J Endourol. 2011;25(6):1013–9.
Kaffenberger SD, Keegan KA, Bansal NK, Morgan TM, Tang DH, Barocas DA, et al. Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J Urol. 2013;189(2):507–13.
Yuh B, Ruel N, Muldrew S, Mejia R, Novara G, Kawachi M, et al. Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience. BJU Int. 2014;113(5):769–76.
Bates AS, Samavedi S, Kumar A, Mouraviev V, Rocco B, Coelho R, et al. Salvage robot assisted radical prostatectomy: a propensity matched study of perioperative, oncological and functional outcomes. Eur J Surg Oncol. 2015;41(11):1540–6.
Bonet X, Ogaya-Pinies G, Woodlief T, Hernandez-Cardona E, Ganapathi H, Rogers T, et al. Nerve sparing in salvage robotic assisted prostatectomy: surgical technique, oncologic and functional outcomes at a single high-volume institution. BJU Int. 2018;122:837–44.
Ogaya-Pinies G, Linares-Espinos E, Hernandez-Cardona E, Jenson C, Cathelineau X, Sanchez-Salas R, et al. Salvage robotic-assisted radical prostatectomy: oncologic and functional outcomes from two high-volume institutions. World J Urol. 2019;37(8):1499–505.
Gontero P, Marra G, Alessio P, Filippini C, Oderda M, Munoz F, et al. Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches. J Urol. 2019;202(4):725–31.
Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009;55(5):1037–63.
Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23(12):2772–80.
Valerio M, Ahmed HU, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R, et al. The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol. 2014;66(4):732–51.
Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L. Oncologic and functional outcomes of partial gland ablation with high intensity focused ultrasound for localized prostate cancer. J Urol. 2019;201(1):113–9.
Nunes-Silva I, Barret E, Srougi V, Baghdadi M, Capogrosso P, Garcia-Barreras S, et al. Effect of prior focal therapy on perioperative, oncologic and functional outcomes of salvage robotic assisted radical prostatectomy. J Urol. 2017;198(5):1069–76.
Marconi L, Stonier T, Tourinho-Barbosa R, Moore C, Ahmed HU, Cathelineau X, et al. Robot-assisted radical prostatectomy after focal therapy: oncological, functional outcomes and predictors of recurrence. Eur Urol. 2019;76(1):27–30.
Herrera-Caceres JO, Nason GJ, Salgado-Sanmamed N, Goldberg H, Woon DTS, Chandrasekar T, et al. Salvage radical prostatectomy following focal therapy: functional and oncological outcomes. BJU Int. 2020;125(4):525–30.
Pierrard V, Lebdai S, Kleinclauss F, Azzouzi AR, Terrier JE, Fortier E, et al. Radical prostatectomy after vascular targeted photodynamic therapy with padeliporfin: feasibility, and early and intermediate results. J Urol. 2019;201(2):315–21.
Onol FF, Bhat S, Moschovas M, Rogers T, Ganapathi H, Roof S, et al. Comparison of outcomes of salvage robot-assisted laparoscopic prostatectomy for post-primary radiation vs focal therapy. BJU Int. 2020;125(1):103–11.
van der Poel HG, Beetsma DB, van Boven H, Horenblas S. Perineal salvage prostatectomy for radiation resistant prostate cancer. Eur Urol. 2007;51(6):1565–71 discussion 1572.
Dobbs RW, Halgrimson WR, Talamini S, Vigneswaran HT, Wilson JO, Crivellaro S. Single-port robotic surgery: the next generation of minimally invasive urology. World J Urol. 2020;38(4):897–905.
Dobbs RW, Halgrimson WR, Madueke I, Vigneswaran HT, Wilson JO, Crivellaro S. Single-port robot-assisted laparoscopic radical prostatectomy: initial experience and technique with the da Vinci((R)) SP platform. BJU Int. 2019;124(6):1022–7.
Maurice MJ, Kaouk JH. Single-port robot-assisted perineal prostatectomy and pelvic lymphadenectomy: step-by-step technique in a cadaveric model. J Endourol. 2018;32(S1):S93–6.
Abdul-Muhsin H, Samavedi S, Pereira C, Palmer K, Patel V. Salvage robot-assisted radical prostatectomy. BJU Int. 2013;111(4):686–7.
Kaffenberger SD, Smith JA. Salvage robotic radical prostatectomy. Indian J Urol. 2014;30(4):429–33.
Mandel P, Linnemannstöns A, Chun F, Schlomm T, Pompe R, Budäus L, et al. Incidence, risk factors, management, and complications of rectal injuries during radical prostatectomy. Eur Urol Focus. 2018;4(4):554–7.
Jamal K, Challacombe B, Elhage O, Popert R, Kirby R, Dasgupta P. Successful salvage robotic-assisted radical prostatectomy after external beam radiotherapy failure. Urology. 2008;72(6):1356–8.
Bianchi L, Turri FM, Larcher A, de Groote R, de Bruyne P, de Coninck V, et al. A novel approach for apical dissection during robot-assisted radical prostatectomy: the “collar” technique. Eur Urol Focus. 2018;4(5):677–85.
Ogaya-Pinies G, Kadakia Y, Palayapalayam-Ganapathi H, Woodlief T, Jenson C, Syed J, et al. Use of scaffolding tissue biografts to bolster vesicourethral anastomosis during salvage robot-assisted prostatectomy reduces leak rates and catheter times. Eur Urol. 2018;74(1):92–8.
Grasso AA, et al. Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta-analysis. BJU Int. 2016;118(1):20–34.
Guru KA, Seereiter PJ, Sfakianos JP, Hutson AD, Mohler JL. Is a cystogram necessary after robot-assisted radical prostatectomy? Urol Oncol. 2007;25(6):465–7.
Marra G, et al. Outcomes of salvage radical prostatectomy for M0 castration-resistant recurrent prostate cancer: a reasonable option in the era of new antiandrogen therapies? Eur Urol Focus. 2020;S2405–4569(20):30103–6.
Porpiglia F, et al. Development and validation of 3D printed virtual models for robot-assisted radical prostatectomy and partial nephrectomy: urologists’ and patients’ perception. World J Urol. 2018;36(2):201–7.
Khan R, Aydin A, Khan MS, Dasgupta P, Ahmed K. Simulation-based training for prostate surgery. BJU Int. 2015;116(4):665–74.
Davis JW, Kamat A, Munsell M, Pettaway C, Pisters L, Matin S. Initial experience of teaching robot-assisted radical prostatectomy to surgeons-in-training: can training be evaluated and standardized? BJU Int. 2010;105(8):1148–54.
Barski D, Gerullis H, Ecke T, Boros M, Brune J, Beutner U, et al. Application of dried human amnion graft to improve post-prostatectomy incontinence and potency: a randomized exploration study protocol. Adv Ther. 2020;37(1):592–602.
Maia G, et al. Bacterial cellulose to reinforce urethrovesical anastomosis. A translational study. Acta Cir Bras. 2018;33(8):673–83.
Simone G, Misuraca L, Anceschi U, Minisola F, Ferriero M, Guaglianone S, et al. Urethra and ejaculation preserving robot-assisted simple prostatectomy: near-infrared fluorescence imaging-guided Madigan technique. Eur Urol. 2019;75(3):492–7.
Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180(2):559–63 discussion 563-4.
Author information
Authors and Affiliations
Contributions
RD (concept, drafting manuscript, and critical revision), MS (drafting manuscript and critical revision), IM (drafting manuscript and critical revision), and DL (drafting manuscript and critical revision).
Corresponding author
Ethics declarations
Conflicts of Interest
Not applicable.
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent to Publication
Not applicable.
Code Availability
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Surgery
Rights and permissions
About this article
Cite this article
Dobbs, R.W., Shahait, M., Madueke, I.C. et al. Robotic Salvage Prostatectomy: a Contemporary Review. SN Compr. Clin. Med. 3, 233–241 (2021). https://doi.org/10.1007/s42399-020-00682-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-020-00682-6